EGFR and metastatic malignant neoplasm in the lymph nodes: Xu et al. suggested that up-regulation of miR-183 in female lung adenocarcinoma was found to be associated with lymph node metastasis, advanced clinical stage, EGFR mutation, poor overall survival and progression-free survival [31].